vaccination at the hatchery injection - transmune€¦ · microbiological monitoring • intensive...
TRANSCRIPT
Carlos González Alonso
Global Technical & Marketing Equipment Manager
Vaccination at the Hatchery
INJECTIONKey factors for process-control
Hatchery Injection Practices - 2012
51 bill.Broilers
What are the
Key Factors for Control
in SQ Vaccination?
CONCEPT SQ
Optimal Vaccination Efficacy +98%
Maximum Recommended Speed
2500-3000 DOCs/hour
Maximum Recommended Time of Operation
6 hours/operator
Maximum Output/Day 18.000 DOCs/operator/day
Recommended Maintenance 1.5 hour/SQ vaccinator/week
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Equipment Setting • Needle: length, orientation and size• Performance: Dosage, accuracy, etc.• Equipment maintenance
Operator Skills & Training • DOC handling technique• Speed impact and working hours• HR availability and turn-over
Supervision & Monitoring • Vaccination Efficacy per operator• Dosage control• Logistics & Organization
Vaccine Handling & Status • Vaccine preparation • Timing and vaccine stability• Impact of equipment on vaccine status
Biosecurity & Contamination • Monitoring of vaccine contamination• Crossed contamination between DOC• Environmental contamination
Sub-Cutaneous Injection
Sub-Cutaneous Injection
Self Injection
Low Accuracy
Unconsistent location
MAIN TOPICS TO CONSIDER Key Factors
Equipment Setting • Needle: length, orientation and size• Performance: Dosage, accuracy, etc.• Equipment maintenance
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Operator skills & training • DOC handling technique• Speed impact and working hours impact• HR availability and turn-over
Sub-Cutaneous Injection
Sub-Cutaneous Injection
VACCINATIONFAILURE
REFERENCEINCIDENCE
2012 DATA (avg.)
IMPACT
No Vaccine <0.5% 1.29% No protection in the fieldVaccine waste
Wet Fluff <0.5% 2.17% Low or no protectionVaccine waste
Mal-position <0.5% 3.81% Low absorption of the vaccineRisk of damages of vascular systemRisk of damages on digestive tract
Blood <0.25% 0.44% Infection of damaged tissuesHigher first week mortality
Bone-damage <0.25% 0.16% Injection at crane or back-spineCull chicks; Mortality
Vaccination Q > 98% 92.13%
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Supervision & Monitoring • Vaccination Efficacy per operator• Dosage control• Logistics & Organization
Sub-Cutaneous Injection
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
7.00%
8.00%
9.00%
10.00%
M ojado M od. 5.73% 4.83% 9.00% 7.90% 5.50% 3.54% 3.29% 2.56% 2.89% 3.18% 3.77% 2.14% 0.60% 2.06% 1.67%
M ojado Sev. 6.18% 3.83% 2.86% 2.80% 1.50% 2.12% 1.59% 0.78% 0.93% 0.30% 1.09% 0.36% 2.53% 0.50% 0.86%
Heridos 1.09% 1.25% 1.14% 0.80% 1.56% 0.92% 1.06% 0.56% 0.43% 0.57% 0.59% 0.50% 0.60% 1.33% 0.33%
M ala Posición 0.45% 0.58% 1.43% 0.60% 0.81% 0.19% 0.41% 0.00% 0.55% 0.27% 0.55% 0.14% 0.00% 0.39% 0.29%
No vacunados 0.00% 0.00% 0.86% 1.10% 0.31% 0.31% 0.47% 0.00% 0.05% 0.07% 0.09% 0.00% 0.33% 0.06% 0.14%
M uertos 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.05% 0.05% 0.05% 0.00% 0.00% 0.00% 0.00%
16-Oct 23-Oct 30-Oct 06-Nov 13-Nov 20-Nov 21-Nov 01-Dic 11-Dic 12-Dic 18-Dic 30-Dic 15-Ene 29-Ene 10-Feb
Data CollectionData Analysis
Sub-Cutaneous Injection
0.00%
1.00%
2.00%
3.00%
4.00%
5.00%
6.00%
7.00%
8.00%
9.00%
10.00%
M ojado M od. 5.73% 4.83% 9.00% 7.90% 5.50% 3.54% 3.29% 2.56% 2.89% 3.18% 3.77% 2.14% 0.60% 2.06% 1.67%
M ojado Sev. 6.18% 3.83% 2.86% 2.80% 1.50% 2.12% 1.59% 0.78% 0.93% 0.30% 1.09% 0.36% 2.53% 0.50% 0.86%
Heridos 1.09% 1.25% 1.14% 0.80% 1.56% 0.92% 1.06% 0.56% 0.43% 0.57% 0.59% 0.50% 0.60% 1.33% 0.33%
M ala Posición 0.45% 0.58% 1.43% 0.60% 0.81% 0.19% 0.41% 0.00% 0.55% 0.27% 0.55% 0.14% 0.00% 0.39% 0.29%
No vacunados 0.00% 0.00% 0.86% 1.10% 0.31% 0.31% 0.47% 0.00% 0.05% 0.07% 0.09% 0.00% 0.33% 0.06% 0.14%
M uertos 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.05% 0.05% 0.05% 0.00% 0.00% 0.00% 0.00%
16-Oct 23-Oct 30-Oct 06-Nov 13-Nov 20-Nov 21-Nov 01-Dic 11-Dic 12-Dic 18-Dic 30-Dic 15-Ene 29-Ene 10-Feb
Sub-Cutaneous Injection
97,25%
95,33%
98,67%
93,00%
84,00%
99,00%
82,00%
96,40%
98,00%
95,90%
96,33%
98,50%
98,33%
98,67%
60%
65%
70%
75%
80%
85%
90%
95%
100%
16
-Oc
t
23
-Oc
t
30
-Oc
t
06
-No
v
13
-No
v
20
-No
v
21
-No
v
01
-dé
c
11
-Dic
12
-Dic
18
-Dic
30
-Dic
15
-En
e
29
-En
e
10
-Fe
b
Vaccinator A
Dates of Audits
Vaccin
ation Q
ualit
y
MAIN TOPICS TO CONSIDER Key Factors
Supervision & Monitoring • Vaccination Efficacy per operator• Dosage control• Logistics & Organization
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Vaccine handling & status • Vaccine preparation • Timing and vaccine stability• Impact of equipment on vaccine status
Sub-Cutaneous Injection
Vaccine titter
loss due to
vaccine tubes
set-up
Sub-Cutaneous Injection
0
1000
2000
3000
4000
5000
6000
7000
8000
PF
U/D
OS
E
7000
6000
5000
4000
3000
2000
1000
0
BAG #1
BAG #2
BAG #3
BAG MACHINE - NEAR MACHINE - FAR
Vaccine titter loss due to vaccine tubes set-up
MAIN TOPICS TO CONSIDER Key Factors
Biosecurity & Contamination • Monitoring of vaccine contamination• Cross contamination between DOC• Environmental contamination
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Biosecurity & Contamination • Monitoring of vaccine contamination• Crossed contamination between DOC• Environmental contamination
Sub-Cutaneous Injection
Sub-Cutaneous Injection
MAIN TOPICS TO CONSIDER Key Factors
Biosecurity & Contamination • Monitoring of vaccine contamination• Crossed contamination between DOC• Environmental contamination
SQ is a simple method, but it
demads skilled operators and
constant monitoring
What are the
Key Factors for Control
in In-Ovo Vaccination?
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Site of Location Test
Monitoring In-Ovo Vaccination
Ideal
Medium
Poor
Early
Embryo development days2017 18 19
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Microbiological Monitoring
• Intensive monitoring of the hatchery and the vaccination process.
• Aspergillus sp. incidence and all major production-related bacteria
(E.Coli, Pseudomonas sp., Salmonella sp., Staphilococus sp., etc…)
• Helps to improve the bio-sanitare status of the hatchery and
secures the in-ovo vaccination process.
Vaccination Micro Control
Regular micro monitoring evaluation of the
vaccination process
Hatchery Micro Control
Yearly monitoring of the hatchery plant
and all production processes
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Monitoring In-Ovo Vaccination
Concept
Young Flocks
(>30w)
Medium Flocks
(30-45w)
Old Flocks
(<45w)
Egg Breakage 0.4% 0.5% 0.5%
Upside-down Eggs 0.3% 0.2% 0.2%
Side Injections 0.25% 0.2% 0.2%
Abnormal Perforation <0.1% <0.1% <0.1%
Blocked Needles <8% 8% 8-10%
Contaminated Eggs 0.25% 0.3% 0.4%
Aspergillus sp. 0.5% 0.5% 0.8%
Monitoring In-Ovo Vaccination
It is KEY to create your own
reference data sheet
Topic Recomended Frequency
Vaccine Prep. Daily
In-Ovo Checklist Daily
Dosage Control Daily
Microbiological Monitoring 15 days
Operator Training Continious
Embryo-diagnosis Daily2-3 flocks
Disinfection Mix Control Daily
Egg Cleaning & Sanitare Status Weekly
Hatchability Assessment Weekly 5-10 flocks
Monitoring In-Ovo Vaccination
Summary
o Hatchery Injection represents 65-70% of
the total Broiler production world-wide with
a strong positive trend.
o Skilled operatos in equipment care and
vaccination technique are requiered for
success.
o Constant monitoring and data analysis
are key factors for improvement.
o The implementation of regular vaccination
services and monitoring activities is
mandatory.
Vaccination at the Hatchery
INJECTIONKey factors for process-control
